Last reviewed · How we verify

NCT06270654

Management of Perioperative Pain Using Erector Spinae Plane Block in Open Microscopic Lumbar Surgery

Status unknown NA Last updated 21 February 2024
What this trial tests

NA trial testing Erector spinae plane block in Lumbar Spine Disease in 40 participants. Status unknown.

Timeline
1 June 2023
Primary endpoint
1 May 2024
1 June 2024

Quick facts

Lead sponsorUniversity of Malaya
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date1 June 2023
Primary completion1 May 2024
Estimated completion1 June 2024
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

University of Malaya

Who can join

Adults 18 to 75, any sex, with Lumbar Spine Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare patients receiving bilateral erector spinae block with ropivacaine vs control group in terms of pain score, total opioid consumption, hemodynamic changes intraoperatively, length of hospitalisation , time to ambulation post surgery and quality of recovery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Erector spinae plane block

Trials testing the same drug.

Other University of Malaya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06270654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing